Jefferson Radiation Oncologist Re-elected to Chair Prestigious Clinical Trials Group
Walter J. Curran Jr., M.D., professor and chair of radiation oncology at Jefferson Medical College at Thomas Jefferson University
in Philadelphia and clinical director of Jefferson’s Kimmel Cancer Center, has been re-elected to a third four-year term as
Group Chair of the Radiation Therapy Oncology Group (RTOG), a Philadelphia-based federally funded cancer clinical trials group
that carries out multi-disciplinary research nationwide and in Canada.
As Group Chair, Dr. Curran serves as chief scientific leader of the organization, in addition to its administrator. He also
is principal investigator of two major National Cancer Institute-funded grants awarded to RTOG to support a number of clinical
trials, in addition to the organization’s Community Clinical Oncology Program (CCOP). CCOP provides communities with the latest
cancer prevention and treatment research findings through participation in clinical trials.
Dr. Curran, one of only four Group Chairs in the organization’s 35 years of existence, looks forward to his ongoing leadership
role.
“RTOG continues to conduct landmark trials and establish new standards of care for brain tumors and for cancers of the head
and neck, lung, gastrointestinal tract and prostate,” says Dr. Curran. “The coming years will be exciting.”
Media Only Contact:Steven BenowitzThomas Jefferson University Hospital
Phone: 215-955-6300
Published: 3-1-2005